AI assistant
MEDIFAST INC — Director's Dealing 2015
Jul 6, 2015
33899_dirs_2015-07-06_c91b612d-a24d-4c4c-8c0f-75212d282155.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MEDIFAST INC (MED)
CIK: 0000910329
Period of Report: 2015-07-01
Reporting Person: SHEETZ MARGARET (President & COO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-07-01 | Common Stock | S | 5533 | $32.52 | Disposed | 397893 | Direct |
| 2015-07-01 | Common Stock | S | 2800 | $32.67 | Disposed | 395093 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 5149 | Indirect |
Footnotes
F1: The sales reported in this Form 4 were made pursuant to a 10b5-1 plan adopted by the reporting person on June 9, 2015.
F2: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.36 to $32.63. The reporting person agrees to provide upon request by the SEC Staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range.
F3: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.64 to $32.71. The reporting person agrees to provide upon request by the SEC Staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range.